EUR 109.5
(-0.73%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.14 Billion EUR | 1.07% |
2022 | 1.13 Billion EUR | 6.77% |
2021 | 1.05 Billion EUR | 13.94% |
2020 | 794.4 Million EUR | 7.65% |
2019 | 152.7 Million EUR | 29.23% |
2018 | 645 Million EUR | 37.24% |
2017 | 486.9 Million EUR | 25.81% |
2016 | 387 Million EUR | 10.07% |
2015 | 351.6 Million EUR | 24.15% |
2014 | 283.2 Million EUR | 12.47% |
2013 | 251.8 Million EUR | 2.13% |
2012 | 198.18 Million EUR | -11.81% |
2011 | 147.99 Million EUR | 4.9% |
2010 | 166.36 Million EUR | 23.02% |
2009 | 216.64 Million EUR | -9.27% |
2008 | 246.78 Million EUR | -8.71% |
2007 | 249.05 Million EUR | 5.43% |
2006 | 237.76 Million EUR | 30.66% |
2005 | 190.4 Million EUR | 17.63% |
2004 | 150.66 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 481.7 Million EUR | 0.0% |
2023 FY | - EUR | 1.07% |
2023 Q4 | 631.3 Million EUR | 0.0% |
2023 Q2 | 491.5 Million EUR | 0.0% |
2022 FY | - EUR | 6.77% |
2022 Q2 | 610.9 Million EUR | 0.0% |
2022 Q4 | 520 Million EUR | 0.0% |
2021 FY | - EUR | 13.94% |
2021 Q2 | 539.6 Million EUR | 0.0% |
2021 Q4 | 519.6 Million EUR | 0.0% |
2020 FY | - EUR | 7.65% |
2020 Q4 | 466.2 Million EUR | 0.0% |
2020 Q2 | 463.4 Million EUR | 0.0% |
2019 Q4 | 472.1 Million EUR | 0.0% |
2019 Q2 | 391.4 Million EUR | 0.0% |
2019 FY | - EUR | 29.23% |
2018 Q4 | 329.7 Million EUR | 0.0% |
2018 FY | - EUR | 37.24% |
2018 Q2 | 338.5 Million EUR | 0.0% |
2017 Q4 | 262.7 Million EUR | 0.0% |
2017 FY | - EUR | 25.81% |
2017 Q2 | 224.2 Million EUR | 0.0% |
2016 Q2 | 205.6 Million EUR | 0.0% |
2016 Q4 | 181.4 Million EUR | 0.0% |
2016 FY | - EUR | 10.07% |
2015 Q4 | 167.5 Million EUR | 0.0% |
2015 Q2 | 184.1 Million EUR | 0.0% |
2015 FY | - EUR | 24.15% |
2014 FY | - EUR | 12.47% |
2014 Q4 | 104 Million EUR | 0.0% |
2014 Q2 | 179.2 Million EUR | 0.0% |
2013 Q2 | 161.7 Million EUR | 0.0% |
2013 Q4 | 90.1 Million EUR | 0.0% |
2013 FY | - EUR | 2.13% |
2012 Q3 | 1.51 Million EUR | 0.0% |
2012 FY | - EUR | -11.81% |
2012 Q1 | 1.51 Million EUR | 0.0% |
2012 Q2 | 1.51 Million EUR | 0.0% |
2012 Q4 | - EUR | -100.0% |
2011 Q2 | -835 Thousand EUR | 0.0% |
2011 Q1 | -835 Thousand EUR | 0.0% |
2011 FY | - EUR | 4.9% |
2011 Q4 | - EUR | 100.0% |
2011 Q3 | -835 Thousand EUR | 0.0% |
2010 FY | - EUR | 23.02% |
2010 Q4 | - EUR | -100.0% |
2010 Q3 | 31.33 Million EUR | 0.0% |
2010 Q1 | 31.33 Million EUR | 0.0% |
2010 Q2 | - EUR | -100.0% |
2009 Q1 | 45.67 Million EUR | -1.43% |
2009 Q2 | 45.67 Million EUR | 0.0% |
2009 Q3 | 45.67 Million EUR | 0.0% |
2009 Q4 | - EUR | -100.0% |
2009 FY | - EUR | -9.27% |
2008 FY | - EUR | -8.71% |
2008 Q4 | 46.33 Million EUR | 0.0% |
2008 Q3 | 46.33 Million EUR | 0.0% |
2008 Q2 | 46.33 Million EUR | 0.0% |
2008 Q1 | 46.33 Million EUR | -15.39% |
2007 FY | - EUR | 5.43% |
2007 Q2 | 54.75 Million EUR | 0.0% |
2007 Q1 | 54.75 Million EUR | 16.9% |
2007 Q3 | 54.75 Million EUR | 0.0% |
2007 Q4 | 54.75 Million EUR | 0.0% |
2006 Q4 | 46.84 Million EUR | 0.0% |
2006 Q3 | 46.84 Million EUR | 0.0% |
2006 Q2 | 46.84 Million EUR | 0.0% |
2006 Q1 | 46.84 Million EUR | 18.29% |
2006 FY | - EUR | 30.66% |
2005 FY | - EUR | 17.63% |
2005 Q1 | 39.6 Million EUR | 28.53% |
2005 Q2 | 39.6 Million EUR | 0.0% |
2005 Q3 | 39.6 Million EUR | 0.0% |
2005 Q4 | 39.6 Million EUR | 0.0% |
2004 Q4 | 30.81 Million EUR | 0.0% |
2004 FY | - EUR | 0.0% |
2004 Q3 | 30.81 Million EUR | 0.0% |
2004 Q2 | 30.81 Million EUR | 0.0% |
2004 Q1 | 30.81 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AB Science S.A. | -9.28 Million EUR | 12415.483% |
Boiron SA | 80.67 Million EUR | -1316.726% |
Fagron NV | 141.94 Million EUR | -705.236% |
Malin Corporation plc | -3.8 Million EUR | 30178.947% |
Vetoquinol SA | 104.58 Million EUR | -992.933% |